Insurance Policy Update: Humana Now Covers SBRT for Prostate Cancer

Insurance Policy Update: Humana Now Covers SBRT for Prostate Cancer

Humana recently announced it has updated its position on stereotactic body radiation therapy (SBRT) for prostate cancer.  A recent policy update now covers SBRT treatment for early and intermediate stage prostate cancer.

The Humana policy change follows similar updates from insurance providers and research organizations across the country that have announced support for SBRT as an appropriate treatment option for prostate cancer.

Results of numerous clinical trials and research studies from renowned experts supporting the safety and effectiveness of SBRT in treating prostate cancer led Humana to update its medical policy.

At Louisville CyberKnife, prostate cancer patients are treated with SBRT using CyberKnife® technology, a powerful, noninvasive treatment system that precisely focuses radiation to match the size and shape of a patient’s prostate cancer, minimizing damage to surrounding tissue.

For more information on Humana’s SRS/SBRT policy change and medically necessary criteria for SBRT treatment of prostate cancer, click here. For more information on the benefits of CyberKnife treatment, click here.